{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:45:58Z","timestamp":1789011958232,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00210-024-03225-1","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T12:02:20Z","timestamp":1719921740000},"page":"9935-9946","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of the effect of empagliflozin on prevention of atrial fibrillation after coronary artery bypass grafting: a double-blind, randomized, placebo-controlled trial"],"prefix":"10.1007","volume":"397","author":[{"given":"Batool","family":"Zarei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyamin","family":"Fazli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Tayyebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abbasi Teshnizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliasghar","family":"Moeinipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Javedanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Javidi Dasht Bayaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malihe","family":"Rahmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Ghavami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hooshang","family":"Mohammadpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"key":"3225_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5935\/1678-9741.20120005","volume":"27","author":"M Abbaszadeh","year":"2012","unstructured":"Abbaszadeh M, Khan ZH, Mehrani F, Jahanmehr H (2012) Perioperative intravenous corticosteroids reduce incidence of atrial fibrillation following cardiac surgery: a randomized study. Rev Bras Cir Cardiovasc 27:18\u201323","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"3225_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/1010-7940(87)90034-0","volume":"1","author":"G Angelini","year":"1987","unstructured":"Angelini G, Penny W, El-Ghamary F, West R, Butchart E, Armistead S, Breckenridge I, Henderson A (1987) The incidence and significance of early pericardial effusion after open heart surgery. Eur J Cardiothorac Surg 1:165\u2013168","journal-title":"Eur J Cardiothorac Surg"},{"key":"3225_CR3","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, B\u00f6hm M, Brunner\u2013La Rocca H-P, Choi D-J, Chopra V, Chuquiure-Valenzuela E, Giannetti N, Gomez-Mesa JE, Janssens S, Januzzi JL, Gonzalez-Juanatey JR, Merkely B, Nicholls SJ, Perrone SV, Pi\u00f1a IL, Ponikowski P, Senni M, Sim D, Spinar J, Squire I, Taddei S, Tsutsui H, Verma S, Vinereanu D, Zhang J, Carson P, Lam CSP, Marx N, Zeller C, Sattar N, Jamal W, Schnaidt S, Schnee JM, Brueckmann M, Pocock SJ, Zannad F, Packer M (2021) Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 385:1451\u20131461","journal-title":"N Engl J Med"},{"key":"3225_CR4","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1097\/00000542-199706000-00026","volume":"86","author":"JL Atlee","year":"1997","unstructured":"Atlee JL (1997) Perioperative cardiac dysrhythmias: diagnosis and management. J Am Soc Anesthesiol 86:1397\u20131424","journal-title":"J Am Soc Anesthesiol"},{"key":"3225_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1540-8191.2005.2004123.x","volume":"20","author":"J Auer","year":"2005","unstructured":"Auer J, Weber T, Berent R, Ng CK, Lamm G, Eber B (2005) Risk factors of postoperative atrial fibrillation after cardiac surgery. J Card Surg 20:425\u2013431","journal-title":"J Card Surg"},{"key":"3225_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119440","volume":"276","author":"MA Azam","year":"2021","unstructured":"Azam MA, Chakraborty P, Si D, Du B, Mass\u00e9 S, Lai PFH, Ha ACT, Nanthakumar K (2021) Anti-arrhythmic and inotropic effects of empagliflozin following myocardial ischemia. Life Sci 276:119440","journal-title":"Life Sci"},{"issue":"262\u2013275","key":"3225_CR7","volume":"8","author":"WL Baker","year":"2014","unstructured":"Baker WL, Smyth LR, Riche DM, Bourret EM, Chamberlin KW, White WB (2014) Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: a systematic review and meta-analysis. J Am Soc Hypertens 8(262\u2013275):e269","journal-title":"J Am Soc Hypertens"},{"key":"3225_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.5935\/1678-9741.20130073","volume":"28","author":"LR Barbieri","year":"2013","unstructured":"Barbieri LR, Sobral ML, Ger\u00f4nimo GM, Santos GG, Sbara\u00edni E, Dorfman FK, Stolf NA (2013) Incidence of stroke and acute renal failure in patients of postoperative atrial fibrillation after myocardial revascularization. Rev Bras Cir Cardiovasc 28:442\u2013448","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"3225_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.33963\/KP.15666","volume":"79","author":"V\u00d6 Bar\u0131\u015f","year":"2021","unstructured":"Bar\u0131\u015f V\u00d6, Din\u00e7soy B, Gedikli E, Erdemb A (2021) Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats. Kardiol Pol 79:53\u201357","journal-title":"Kardiol Pol"},{"key":"3225_CR10","first-page":"1","volume":"34","author":"V\u00d6 Bar\u0131\u015f","year":"2023","unstructured":"Bar\u0131\u015f V\u00d6, Gedikli E, Din\u00e7soy AB, Erdem A (2023) Empagliflozin significantly prevents QTc prolongation due to amitriptyline intoxication. Cardiovasc J Afr 34:1\u20135","journal-title":"Cardiovasc J Afr"},{"key":"3225_CR11","doi-asserted-by":"crossref","unstructured":"Baris VO, Dincsoy B, Gedikli E, Erdem A (2020) Empagliflozin significantly attenuates QTc prolongation in rats due to sotalol. Eur Heart J 41. Issue Supplement_2.","DOI":"10.1093\/ehjci\/ehaa946.3348"},{"key":"3225_CR12","doi-asserted-by":"crossref","unstructured":"Baysan O, Ocakl\u0131 E, Kayhan Altuner T, Kocaman SA (2017) Atria: a comprehensive evaluation with echocardiography. Heart Vessels Transplant 1:11\u201319","DOI":"10.24969\/hvt.2017.8"},{"key":"3225_CR13","doi-asserted-by":"crossref","unstructured":"Bode D, Semmler L, Wakula P, Hegemann N, Primessnig U, Beindorff N, Powell D, Dahmen R, Ruetten H, Oeing C, Alogna A, Messroghli D, Pieske BM, Heinzel FR, Hohendanner F (2021) Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF.\u00a0Cardiovasc Diabetol 20(1):7","DOI":"10.1186\/s12933-020-01208-z"},{"key":"3225_CR14","first-page":"316","volume":"30","author":"MS Bohatch J\u00fanior","year":"2015","unstructured":"Bohatch J\u00fanior MS, Matkovski PD, Di Giovanni FJ, Fenili R, Varella EL, Dietrich A (2015) Incidence of postoperative atrial fibrillation in patients undergoing on-pump and off-pump coronary artery bypass grafting. Rev Bras Cir Cardiovasc 30:316\u2013324","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"3225_CR15","doi-asserted-by":"crossref","unstructured":"Chen HY, Huang JY, Siao WZ, Jong GP (2020) The association between SGLT2 inhibitors and new-onset arrhythmias: a nationwide population-based longitudinal cohort study.\u00a0Cardiovasc Diabetol 19(1):73","DOI":"10.1186\/s12933-020-01048-x"},{"key":"3225_CR16","doi-asserted-by":"crossref","unstructured":"Curtain JP, Docherty KF (2021) Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.\u00a0Eur Heart J 42(36):3727\u20133738","DOI":"10.1093\/eurheartj\/ehab560"},{"key":"3225_CR17","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.hrthm.2021.03.028","volume":"18","author":"GC Fernandes","year":"2021","unstructured":"Fernandes GC, Fernandes A, Cardoso R, Penalver J, Knijnik L, Mitrani RD, Myerburg RJ, Goldberger JJ (2021) Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: a meta-analysis of 34 randomized controlled trials. Heart Rhythm 18:1098\u20131105","journal-title":"Heart Rhythm"},{"key":"3225_CR18","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/circ.114.4.257","volume":"114","author":"V Fuster","year":"2006","unstructured":"Fuster V, Ryd\u00e9n LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL (2006) ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114:e257-354","journal-title":"Circulation"},{"key":"3225_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s13054-015-1007-5","volume":"19","author":"J Gamst","year":"2015","unstructured":"Gamst J, Christiansen CF, Rasmussen BS, Rasmussen LH, Thomsen RW (2015) Pre-existing atrial fibrillation and risk of arterial thromboembolism and death in intensive care unit patients: a population-based cohort study. Crit Care 19:299","journal-title":"Crit Care"},{"key":"3225_CR20","doi-asserted-by":"publisher","first-page":"1011429","DOI":"10.3389\/fcvm.2022.1011429","volume":"9","author":"J Gao","year":"2022","unstructured":"Gao J, Xue G, Zhan G, Wang X, Li J, Yang X, Xia Y (2022) Benefits of SGLT2 inhibitors in arrhythmias. Front Cardiovasc Med 9:1011429","journal-title":"Front Cardiovasc Med"},{"key":"3225_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13098-018-0395-5","volume":"10","author":"S Hattori","year":"2018","unstructured":"Hattori S (2018) Anti-inflammatory effects of empagliflozin in patients with type 2 diabetes and insulin resistance. Diabetol Metab Syndr 10:93","journal-title":"Diabetol Metab Syndr"},{"key":"3225_CR22","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79:e263\u2013e421","journal-title":"J Am Coll Cardiol"},{"key":"3225_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13019-017-0609-1","volume":"12","author":"MF Ismail","year":"2017","unstructured":"Ismail MF, El-mahrouk AF, Hamouda TH, Radwan H, Haneef A, Jamjoom AA (2017) Factors influencing postoperative atrial fibrillation in patients undergoing on-pump coronary artery bypass grafting, single center experience. J Cardiothorac Surg 12:40","journal-title":"J Cardiothorac Surg"},{"key":"3225_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.898718","volume":"13","author":"Y Jing","year":"2022","unstructured":"Jing Y, Yang R, Chen W, Ye Q (2022) Anti-arrhythmic effects of sodium-glucose co-transporter 2 inhibitors. Front Pharmacol 13:898718","journal-title":"Front Pharmacol"},{"key":"3225_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","volume":"83","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, Gorenek B, Hess PL, Hlatky M, Hogan G, Ibeh C, Indik JH, Kido K, Kusumoto F, Link MS, Linta KT, Marcus GM, McCarthy PM, Patel N, Patton KK, Perez MV, Piccini JP, Russo AM, Sanders P, Streur MM, Thomas KL, Times S, Tisdale JE, Valente AM, Wagoner DRV (2024) 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation. J Am Coll Cardiol 83:109\u2013279","journal-title":"J Am Coll Cardiol"},{"key":"3225_CR26","doi-asserted-by":"publisher","first-page":"H341","DOI":"10.1152\/ajpheart.00391.2022","volume":"324","author":"T Kadosaka","year":"2023","unstructured":"Kadosaka T, Watanabe M, Natsui H, Koizumi T, Nakao M, Koya T, Hagiwara H, Kamada R, Temma T, Karube F (2023) Empagliflozin attenuates arrhythmogenesis in diabetic cardiomyopathy by normalizing intracellular Ca2+ handling in ventricular cardiomyocytes. Am J Physiol-Heart Circ Physiol 324:H341\u2013H354","journal-title":"Am J Physiol-Heart Circ Physiol"},{"key":"3225_CR27","doi-asserted-by":"crossref","unstructured":"Kolesnik E, Scherr D, Rohrer U (2022) SGLT2 inhibitors and their antiarrhythmic properties.\u00a0Int J Mol Sci 23(3):1678","DOI":"10.3390\/ijms23031678"},{"key":"3225_CR28","doi-asserted-by":"crossref","unstructured":"Kowalska K, Walczak J, Femlak J, M\u0142ynarska E, Franczyk B, Rysz J (2021) Empagliflozin-a new chance for patients with chronic heart failure. Pharmaceuticals (Basel, Switzerland) 15(1):47","DOI":"10.3390\/ph15010047"},{"key":"3225_CR29","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1001\/jama.291.14.1720","volume":"291","author":"JP Mathew","year":"2004","unstructured":"Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT (2004) A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 291:1720\u20131729","journal-title":"JAMA"},{"key":"3225_CR30","doi-asserted-by":"crossref","unstructured":"McDonagh TA, Metra M (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.\u00a0Eur Heart J 42(36):3599\u20133726","DOI":"10.1093\/eurheartj\/ehab670"},{"key":"3225_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s13300-014-0063-1","volume":"5","author":"JB McGill","year":"2014","unstructured":"McGill JB (2014) The SGLT2 inhibitor empagliflozin for the treatment of type 2 diabetes mellitus: a bench to bedside review. Diabetes Ther 5:43\u201363","journal-title":"Diabetes Ther"},{"key":"3225_CR32","doi-asserted-by":"crossref","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, B\u011blohl\u00e1vek J, B\u00f6hm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Duk\u00e1t A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O\u2019Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction.\u00a0N Engl J Med 381:1995\u20132008","DOI":"10.1056\/NEJMoa1911303"},{"key":"3225_CR33","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1161\/HYPERTENSIONAHA.122.19586","volume":"79","author":"P Mone","year":"2022","unstructured":"Mone P, Varzideh F, Jankauskas SS, Pansini A, Lombardi A, Frullone S, Santulli G (2022) SGLT2 inhibition via empagliflozin improves endothelial function and reduces mitochondrial oxidative stress: insights from frail hypertensive and diabetic patients. Hypertension 79:1633\u20131643","journal-title":"Hypertension"},{"key":"3225_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jjcc.2016.12.001","volume":"70","author":"EMJP Mouws","year":"2017","unstructured":"Mouws EMJP, Yaksh A, Knops P, Kik C, Boersma E, Bogers AJJC, de Groot NMS (2017) Early ventricular tachyarrhythmias after coronary artery bypass grafting surgery: is it a real burden? J Cardiol 70:263\u2013270","journal-title":"J Cardiol"},{"key":"3225_CR35","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.017483","volume":"10","author":"R Nishinarita","year":"2021","unstructured":"Nishinarita R, Niwano S, Niwano H, Nakamura H, Saito D, Sato T, Matsuura G, Arakawa Y, Kobayashi S, Shirakawa Y, Horiguchi A, Ishizue N, Igarashi T, Yoshizawa T, Oikawa J, Hara Y, Katsumura T, Kishihara J, Satoh A, Fukaya H, Sakagami H, Ako J (2021) Canagliflozin suppresses atrial remodeling in a canine atrial fibrillation model. J Am Heart Assoc 10:e017483","journal-title":"J Am Heart Assoc"},{"key":"3225_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.33963\/KP.15666","volume":"79","author":"V \u00d6zg\u00fcr Bar\u0131\u015f","year":"2021","unstructured":"\u00d6zg\u00fcr Bar\u0131\u015f V, Din\u00e7soy B, Gedikli E, Erdemb A (2021) Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats. Kardiol Pol 79:53\u201357","journal-title":"Kardiol Pol"},{"key":"3225_CR37","doi-asserted-by":"crossref","unstructured":"Paasche A, Wiedmann F, Kraft M, Seibertz F, Herlt V, Blochberger PL, J\u00e1vorszky N, Beck M, Weirauch L, Seeger T, Blank A, Haefeli WE, Arif R, Meyer AL, Warnecke G, Karck M, Voigt N, Frey N, Schmidt C (2024) Acute antiarrhythmic effects of SGLT2 inhibitors-dapagliflozin lowers the excitability of atrial cardiomyocytes.\u00a0Basic Res Cardiol\u00a0119(1):93\u2013112","DOI":"10.1007\/s00395-023-01022-0"},{"key":"3225_CR38","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, Jamal W, Kimura K, Schnee J, Zeller C, Cotton D, Bocchi E, B\u00f6hm M, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Janssens S, Zhang J, Gonzalez Juanatey JR, Kaul S, Brunner-La Rocca HP, Merkely B, Nicholls SJ, Perrone S, Pina I, Ponikowski P, Sattar N, Senni M, Seronde MF, Spinar J, Squire I, Taddei S, Wanner C, Zannad F (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383:1413\u20131424","journal-title":"N Engl J Med"},{"key":"3225_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/615987","volume":"2014","author":"G Peretto","year":"2014","unstructured":"Peretto G, Durante A, Limite LR, Cianflone D (2014) Postoperative arrhythmias after cardiac surgery: incidence, risk factors, and therapeutic management. Cardiol Res Pract 2014:615987","journal-title":"Cardiol Res Pract"},{"key":"3225_CR40","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1161\/CIRCULATIONAHA.121.053350","volume":"143","author":"K Philippaert","year":"2021","unstructured":"Philippaert K, Kalyaanamoorthy S, Fatehi M, Long W, Soni S, Byrne NJ, Barr A, Singh J, Wong J, Palechuk T (2021) Cardiac late sodium channel current is a molecular target for the sodium\/glucose cotransporter 2 inhibitor empagliflozin. Circulation 143:2188\u20132204","journal-title":"Circulation"},{"key":"3225_CR41","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0002-8703(95)90332-1","volume":"129","author":"LA Pires","year":"1995","unstructured":"Pires LA, Wagshal AB, Lancey R, Huang SKS (1995) Arrhythmias and conduction disturbances after coronary artery bypass graft surgery: epidemiology, management, and prognosis. Am Heart J 129:799\u2013808","journal-title":"Am Heart J"},{"key":"3225_CR42","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s10787-021-00797-9","volume":"29","author":"M Pirklbauer","year":"2021","unstructured":"Pirklbauer M (2021) Anti-inflammatory potential of Empagliflozin. Inflammopharmacology 29:573\u2013576","journal-title":"Inflammopharmacology"},{"key":"3225_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1475-2840-12-70","volume":"12","author":"A Ring","year":"2013","unstructured":"Ring A, Brand T, Macha S, Breithaupt-Groegler K, Simons G, Walter B, Woerle HJ, Broedl UC (2013) The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study. Cardiovasc Diabetol 12:70","journal-title":"Cardiovasc Diabetol"},{"key":"3225_CR44","doi-asserted-by":"crossref","unstructured":"Seo EJ, Hong J, Lee HJ, Son YJ (2021) Perioperative risk factors for new-onset postoperative atrial fibrillation after coronary artery bypass grafting: a systematic review.\u00a0BMC cardiovascular disorders\u00a021(1):418","DOI":"10.1186\/s12872-021-02224-x"},{"key":"3225_CR45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1590\/S0102-76382010000200009","volume":"25","author":"RG Silva","year":"2010","unstructured":"Silva RG, Lima GG, Guerra N, Bigolin AV, Petersen LC (2010) Risk index proposal to predict atrial fibrillation after cardiac surgery. Rev Bras Cir Cardiovasc 25:183\u2013189","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"3225_CR46","doi-asserted-by":"publisher","first-page":"8689","DOI":"10.1038\/s41598-023-35944-5","volume":"13","author":"D Silva Dos Santos","year":"2023","unstructured":"Silva Dos Santos D, Tura\u00e7a LT, Coutinho K, Barbosa RAQ, Polidoro JZ, Kasai-Brunswick TH, Campos de Carvalho AC, Girardi ACC (2023) Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1. Sci Rep 13:8689","journal-title":"Sci Rep"},{"key":"3225_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0002-9149(00)00829-8","volume":"86","author":"SC Stamou","year":"2000","unstructured":"Stamou SC, Dangas G, Hill PC, Pfister AJ, Dullum MK, Boyce SW, Bafi AS, Garcia JM, Corso PJ (2000) Atrial fibrillation after beating heart surgery. Am J Cardiol 86:64\u201367","journal-title":"Am J Cardiol"},{"key":"3225_CR48","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1161\/CIRCULATIONAHA.104.531152","volume":"112","author":"V Tomic","year":"2005","unstructured":"Tomic V, Ru\u00dfwurm S, Moller E, Claus RA, Bl\u00e4ss M, Brunkhorst F, Bruegel M, Bode K, Bloos F, Wippermann J (2005) Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation 112:2912\u20132920","journal-title":"Circulation"},{"key":"3225_CR49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3949\/ccjm.88a.20088","volume":"88","author":"Y Tsushima","year":"2021","unstructured":"Tsushima Y, Lansang MC, Makin V (2021) The role of SGLT-2 inhibitors in managing type 2 diabetes. Clevel Clin J Med 88:47\u201358","journal-title":"Clevel Clin J Med"},{"key":"3225_CR50","first-page":"191","volume":"12","author":"S Watanabe","year":"2020","unstructured":"Watanabe S, Singh RB (2020) Can SGLT2 inhibition with empagliflozin attenuate cardiorenal oxidative stress due to its antioxidant effects? World Heart Journal 12:191\u2013197","journal-title":"World Heart Journal"},{"key":"3225_CR51","doi-asserted-by":"crossref","unstructured":"Wu J, Liu Y, Wei X, Zhang X, Ye Y, Li W, Su X (2022) Antiarrhythmic effects and mechanisms of sodium-glucose cotransporter 2 inhibitors: a mini review.\u00a0Front Cardiovasc Med\u00a09:915455","DOI":"10.3389\/fcvm.2022.915455"},{"key":"3225_CR52","doi-asserted-by":"crossref","unstructured":"Xue G, Yang X, Zhan G, Wang X, Gao J, Zhao Y, Wang X, Li J, Pan Z, Xia Y (2022) Sodium\u2013glucose cotransporter 2 inhibitor empagliflozin decreases ventricular arrhythmia susceptibility by alleviating electrophysiological remodeling post-myocardial-infarction in mice.\u00a0Front Pharmacol\u00a013:988408","DOI":"10.3389\/fphar.2022.988408"},{"key":"3225_CR53","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1161\/CIRCULATIONAHA.105.553743","volume":"112","author":"A Zacharias","year":"2005","unstructured":"Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah AS, Habib RH (2005) Obesity and risk of new-onset atrial fibrillation after cardiac surgery. Circulation 112:3247\u20133255","journal-title":"Circulation"},{"key":"3225_CR54","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","volume":"141","author":"TA Zelniker","year":"2020","unstructured":"Zelniker TA, Bonaca MP, Furtado RHM, Mosenzon O, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Budaj A, Kiss RG, Padilla F, Gause-Nilsson I, Langkilde AM, Raz I, Sabatine MS, Wiviott SD (2020) Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 trial. Circulation 141:1227\u20131234","journal-title":"Circulation"},{"key":"3225_CR55","doi-asserted-by":"crossref","unstructured":"Zhang H-D, Ding L, Mi L-J, Zhang A-K, Zhang K, Jiang Z-H, Yu F-Y, Yan X-X, Shen Y-J, Tang M (2023) Sodium\u2013glucose co-transporter-2 inhibitors for the prevention of atrial fibrillation: a systemic review and meta-analysis.\u00a0Eur J Prev Cardiol\u00a031(7):770\u2013779","DOI":"10.1093\/eurjpc\/zwad356"},{"key":"3225_CR56","volume-title":"Braunwald\u2019s heart disease: a textbook of cardiovascular medicine","author":"DP Zipes","year":"2019","unstructured":"Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E (2019) Braunwald\u2019s heart disease: a textbook of cardiovascular medicine. Elsevier"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03225-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T07:06:35Z","timestamp":1732172795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03225-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["3225"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03225-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,2]]},"assertion":[{"value":"28 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local Ethics Committee of Mashhad University of Medical Sciences (MUMS) approved the study protocol (reference number: IR.MUMS.REC.1401.129), and the study was registered on the Iranian registry of clinical trials as IRCT20120520009801N9. Protocol of the study was explained to all participants, and signed written consent forms were obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}